How Drug Companies Use Intellectual-Property Laws to Price Gouge the Public

The New York Times editorial board does not relish alienating big business. So plenty of heads turned last week when the Gray Lady threw down a gauntlet in a full-column editorial titled “Save America’s Patent System.” The Times editorialists excoriated Big Pharma for abusing the American intellectual-propert...